Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

GREEN REVERSE-PHASE – HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY APPROACH FOR STABILITY-INDICATING SIMULTANEOUS QUANTIFICATION OF DORAVIRINE, LAMIVUDINE, AND TENOFOVIR IN BULK AND DOSAGE FORMS

View through CrossRef
Objective: A simple, accurate, and validated reverse-phase high-performance liquid chromatography (HPLC) method was developed for the simultaneous estimation of doravirine, lamivudine, and tenofovir in pharmaceutical formulations. Methods: Chromatographic separation was achieved using a Zorbax Eclipse Plus C18 column (2.1×150 mm, 5 μm) with a mobile phase composed of 0.01 M potassium phosphate buffer (pH adjusted with orthophosphoric acid) and HPLC-grade acetonitrile, delivered at a flow rate of 1 mL/min. Detection was performed at 244 nm. Results: The method yielded sharp, well-resolved peaks with retention times of 2.195 min for doravirine, 2.715 min for lamivudine, and 3.676 min for tenofovir. A peak resolution of 4.4 confirmed efficient separation. The method exhibited excellent linearity with a correlation coefficient (R²) of 0.9999 across concentration ranges of 2.515 μg/mL for doravirine and 7.545 μg/mL for both lamivudine and tenofovir. Accuracy was confirmed through recovery studies, yielding 100.02% for doravirine, 100.09% for lamivudine, and 99.98% for tenofovir. The method also demonstrated high sensitivity, with limits of detection of 0.01 μg/mL for doravirine and 0.11 μg/mL for both lamivudine and tenofovir. The respective limits of quantification were 0.04 μg/mL, 0.32 μg/mL, and 0.34 μg/mL. The regression equations derived were as follows: y=30936x +3374.3 for doravirine, y=29559x+889.66 for lamivudine, and y=29768x+3035.2 for tenofovir. Conclusion: In addition to its strong analytical performance, the method was evaluated using the AGREE metric for green analytical chemistry compliance. Despite the use of acetonitrile, it achieved an AGREE score of 0.73, indicating good environmental compatibility due to minimal solvent consumption, energy efficiency, and avoidance of derivatization. This method – with its short runtime, high accuracy, cost-effectiveness, and environmentally responsible design – is highly suitable for routine quality control and stability studies of antiretroviral pharmaceutical formulations.
Title: GREEN REVERSE-PHASE – HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY APPROACH FOR STABILITY-INDICATING SIMULTANEOUS QUANTIFICATION OF DORAVIRINE, LAMIVUDINE, AND TENOFOVIR IN BULK AND DOSAGE FORMS
Description:
Objective: A simple, accurate, and validated reverse-phase high-performance liquid chromatography (HPLC) method was developed for the simultaneous estimation of doravirine, lamivudine, and tenofovir in pharmaceutical formulations.
Methods: Chromatographic separation was achieved using a Zorbax Eclipse Plus C18 column (2.
1×150 mm, 5 μm) with a mobile phase composed of 0.
01 M potassium phosphate buffer (pH adjusted with orthophosphoric acid) and HPLC-grade acetonitrile, delivered at a flow rate of 1 mL/min.
Detection was performed at 244 nm.
Results: The method yielded sharp, well-resolved peaks with retention times of 2.
195 min for doravirine, 2.
715 min for lamivudine, and 3.
676 min for tenofovir.
A peak resolution of 4.
4 confirmed efficient separation.
The method exhibited excellent linearity with a correlation coefficient (R²) of 0.
9999 across concentration ranges of 2.
515 μg/mL for doravirine and 7.
545 μg/mL for both lamivudine and tenofovir.
Accuracy was confirmed through recovery studies, yielding 100.
02% for doravirine, 100.
09% for lamivudine, and 99.
98% for tenofovir.
The method also demonstrated high sensitivity, with limits of detection of 0.
01 μg/mL for doravirine and 0.
11 μg/mL for both lamivudine and tenofovir.
The respective limits of quantification were 0.
04 μg/mL, 0.
32 μg/mL, and 0.
34 μg/mL.
The regression equations derived were as follows: y=30936x +3374.
3 for doravirine, y=29559x+889.
66 for lamivudine, and y=29768x+3035.
2 for tenofovir.
Conclusion: In addition to its strong analytical performance, the method was evaluated using the AGREE metric for green analytical chemistry compliance.
Despite the use of acetonitrile, it achieved an AGREE score of 0.
73, indicating good environmental compatibility due to minimal solvent consumption, energy efficiency, and avoidance of derivatization.
This method – with its short runtime, high accuracy, cost-effectiveness, and environmentally responsible design – is highly suitable for routine quality control and stability studies of antiretroviral pharmaceutical formulations.

Related Results

Population Pharmacokinetic Analysis of Doravirine in Real-World People with HIV
Population Pharmacokinetic Analysis of Doravirine in Real-World People with HIV
Aim: The pharmacokinetics of doravirine have been studied in clinical trials, but not in real-world settings. Our study aims to characterize and identify factors influencing doravi...
Female Genital Tract Host Factors and Tenofovir and Lamivudine Active Metabolites
Female Genital Tract Host Factors and Tenofovir and Lamivudine Active Metabolites
Abstract Background We previously reported the effect of contraception on cervical tenofovir concentrations in Ugandan women wit...
Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients
Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients
Background: Tenofovir disoproxil fumarate is a prodrug of tenofovir diphosphate that exposes patients to renal toxicity over the long term. Tenofovir alafenamide, a new prodrug, no...
Pharmacokinetic Study of Tenofovir Disoproxil Fumarate Combined with Rifampin in Healthy Volunteers
Pharmacokinetic Study of Tenofovir Disoproxil Fumarate Combined with Rifampin in Healthy Volunteers
ABSTRACT Tenofovir disoproxil fumarate (tenofovir DF) was studied in combination with rifampin in 24 healthy subjects in a multiple-dose, open-label, single-...
Tenofovir Overdosage-A Rarely Reported Phenomenon in Literature
Tenofovir Overdosage-A Rarely Reported Phenomenon in Literature
Introduction: Hepatitis B virus (HBV) has infected affected thirty three percent of the world population, two billion have been infected worldwide and out of them, 350 million suff...
Chromatography, Liquid
Chromatography, Liquid
AbstractThis article describes the modern practice of analytical high performance liquid chromatography (HPLC). Liquid chromatography involves the separation of compounds by differ...

Back to Top